What is the address of JULIE JACOBS KLINISCH BIOLOOG?

The registered office of JULIE JACOBS KLINISCH BIOLOOG is located at Smisstraat 67, 3080 Tervuren.

Is JULIE JACOBS KLINISCH BIOLOOG still active?

Yes. According to the CBE (17 September 2026) JULIE JACOBS KLINISCH BIOLOOG is active, legal situation “Normale toestand”, started on 20 December 2018.

Is JULIE JACOBS KLINISCH BIOLOOG registered on Peppol?

Yes, JULIE JACOBS KLINISCH BIOLOOG is registered on the Peppol network with ID 0208:0716718944.

What is the enterprise number of JULIE JACOBS KLINISCH BIOLOOG?

The enterprise number of JULIE JACOBS KLINISCH BIOLOOG is BE0716718944.

When was JULIE JACOBS KLINISCH BIOLOOG founded?

JULIE JACOBS KLINISCH BIOLOOG was founded on 20 December 2018.

Who are the directors of JULIE JACOBS KLINISCH BIOLOOG?

According to the 2025 annual accounts, the directors of JULIE JACOBS KLINISCH BIOLOOG are: Julie Jacobs.

Is JULIE JACOBS KLINISCH BIOLOOG a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 December 2018; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did JULIE JACOBS KLINISCH BIOLOOG make in 2025?

JULIE JACOBS KLINISCH BIOLOOG posted a profit after taxes of € 86,275 in financial year 2025.

What is the revenue of JULIE JACOBS KLINISCH BIOLOOG?

As a small company, JULIE JACOBS KLINISCH BIOLOOG is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 207,304.

JULIE JACOBS KLINISCH BIOLOOG (Private Limited)

Dossier JULIE JACOBS KLINISCH BIOLOOG, printed on 17 September 2026 from databakkes.be/en/0716718944/julie-jacobs-klinisch-bioloog. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

JULIE JACOBS KLINISCH BIOLOOG from Tervuren, company number BE0716718944, closed financial year 2025 with a result of € 86,275 after tax. For that financial year JULIE JACOBS KLINISCH BIOLOOG recorded a gross margin of € 207,304 and equity of € 67,359. Compared with financial year 2024, the result moved from € 7,166 to € 86,275. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Healthy

€ 67,359

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 86,275

▲ € 79,109 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 126,275

▲ 123% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 86,275 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 13,545

▼ 39% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 8,028

▲ 1% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 1,103

▲ 212% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 1,638

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 165,327 Gross margin 2022: € 165,327 First fiscal year in the series	€ 168,372 Gross margin 2023: € 168,372 ▲ 2% vs 2022 (€ 165,327) Favourable step	€ 134,756 Gross margin 2024: € 134,756 ▼ 20% vs 2023 (€ 168,372) Unfavourable step	€ 207,304 Gross margin 2025: € 207,304 ▲ 54% vs 2024 (€ 134,756) Favourable step	▲ 54%
Profit after taxes	€ 117,209 Profit after taxes 2022: € 117,209 First fiscal year in the series	€ 120,845 Profit after taxes 2023: € 120,845 ▲ 3% vs 2022 (€ 117,209) Favourable step	€ 7,166 Profit after taxes 2024: € 7,166 ▼ 94% vs 2023 (€ 120,845) Unfavourable step	€ 86,275 Profit after taxes 2025: € 86,275 ▲ € 79,109 vs 2024 (€ 7,166) Favourable step	▲ € 79,109
Equity	€ 316,877 Equity 2022: € 316,877 First fiscal year in the series	€ 67,359 Equity 2023: € 67,359 ▼ 79% vs 2022 (€ 316,877) Unfavourable step	€ 67,359 Equity 2024: € 67,359 Unchanged (€ 67,359) Unchanged	€ 67,359 Equity 2025: € 67,359 Unchanged (€ 67,359) Unchanged
Total debts	€ 22,432 Total debts 2022: € 22,432 First fiscal year in the series	€ 137,577 Total debts 2023: € 137,577 ▲ € 115,146 vs 2022 (€ 22,432) Unfavourable step	€ 17,934 Total debts 2024: € 17,934 ▼ 87% vs 2023 (€ 137,577) Favourable step	€ 78,709 Total debts 2025: € 78,709 ▲ € 60,775 vs 2024 (€ 17,934) Unfavourable step	▲ € 60,775
Cash	€ 203,445 Cash 2022: € 203,445 First fiscal year in the series	€ 107,342 Cash 2023: € 107,342 ▼ 47% vs 2022 (€ 203,445) Unfavourable step	€ 56,738 Cash 2024: € 56,738 ▼ 47% vs 2023 (€ 107,342) Unfavourable step	€ 126,275 Cash 2025: € 126,275 ▲ 123% vs 2024 (€ 56,738) Favourable step	▲ 123%
Retained profit	€ 298,277 Retained profit 2022: € 298,277 First fiscal year in the series	€ 48,759 Retained profit 2023: € 48,759 ▼ 84% vs 2022 (€ 298,277) Unfavourable step	€ 48,759 Retained profit 2024: € 48,759 Unchanged (€ 48,759) Unchanged	€ 48,759 Retained profit 2025: € 48,759 Unchanged (€ 48,759) Unchanged
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 370,363 Dividend 2023: € 370,363 Unchanged (€ 0) Unchanged	€ 7,166 Dividend 2024: € 7,166 ▼ 98% vs 2023 (€ 370,363) Unchanged	€ 86,275 Dividend 2025: € 86,275 ▲ € 79,109 vs 2024 (€ 7,166) Unchanged	▲ € 79,109
Bank debt	€ 8,333 Bank debt 2022: € 8,333 First fiscal year in the series	€ 8,457 Bank debt 2023: € 8,457 ▲ 1% vs 2022 (€ 8,333) Unfavourable step	€ 7,912 Bank debt 2024: € 7,912 ▼ 6% vs 2023 (€ 8,457) Favourable step	€ 8,028 Bank debt 2025: € 8,028 ▲ 1% vs 2024 (€ 7,912) Unfavourable step	▲ 1%
Balance sheet total	€ 339,309 Balance sheet total 2022: € 339,309 First fiscal year in the series	€ 204,937 Balance sheet total 2023: € 204,937 ▼ 40% vs 2022 (€ 339,309) Unchanged	€ 175,526 Balance sheet total 2024: € 175,526 ▼ 14% vs 2023 (€ 204,937) Unchanged	€ 238,842 Balance sheet total 2025: € 238,842 ▲ 36% vs 2024 (€ 175,526) Unchanged	▲ 36%

Key figures of JULIE JACOBS KLINISCH BIOLOOG, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to JULIE JACOBS KLINISCH BIOLOOG?

What happened at JULIE JACOBS KLINISCH BIOLOOG in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 30, 2026 New annual accounts for financial year 2025: profit of € 86,275 (▲ € 79,109 vs 2024). Source: NBB ↗
Dec 20, 2018 New establishment in Etterbeek. KBO
2018 Julie Jacobs became a director. NBB
Dec 20, 2018 Start of the company according to the CBE. KBO

In short

From € 117,209 profit in 2022 to € 86,275 profit in 2025.

Paid € 131,893 in corporate taxes since 2022.

Best year ever: 2023, with € 120,845 profit.

Paid out € 463,804 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at JULIE JACOBS KLINISCH BIOLOOG? We notify you, reason included.

Follow JULIE JACOBS KLINISCH BIOLOOG

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Julie Jacobs

JULIE JACOBS KLINISCH BIOLOOG

Behind JULIE JACOBS KLINISCH BIOLOOG is Julie Jacobs.

See the full network in the app

Directors

According to the 2025 annual accounts

Julie Jacobs

Director

since 2018

Establishments

Establishment units

Physical locations of this company

Registered office

Smisstraat 67

3080 Tervuren

2.283.116.219

Louis Schmidtlaan 2/D/b4

1040 Etterbeek

Active since 20 December 2018

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

ASSOCIATION FAMILIALE HAVESKERCKE FAMILIEVERENIGING

TPC Leadership Belgium

€ 94,544 gross margin · 2025

WINCH LEADERSHIP

€ 19,266 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0716.718.944
VAT number: BE 0716.718.944
Registered office: Smisstraat 67, 3080 Tervuren
Names & denominations: JULIE JACOBS KLINISCH BIOLOOG
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 20 December 2018
Peppol: Active · Active since 14 Oct 2025

View on CBE Public ↗ Annual accounts (NBB) ↗